AI assistant
Sending…
GENTEX CORP — Director's Dealing 2020
Feb 4, 2020
30893_dirs_2020-02-04_5b4e2051-9ec1-4396-bcbc-afa3f364a1fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2020-02-03
Reporting Person: Wallace James H (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-03 | Common Stock | M | 12000.00 | $12.365 | Acquired | 33803.00 | Direct |
| 2020-02-03 | Common Stock | S | 12000.00 | $30.0567 | Disposed | 21803.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-03 | Non-Employee Director Stock Option Grant | $12.365 | M | 12000.00 | Disposed | 2023-05-16 | Common Stock (12000.00) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $30.0469 to $30.075. The price reported above reflects the weighted average price.
F2: Options are fully vested.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19